Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 930-915-9 | CAS number: 1318-02-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- Sep. 9, 1999 - Mr. 29, 2000; experimental phase: Oct. 4 - Nov. 12, 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1997-07-21
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- Zeolite, cuboidal, crystalline, synthetic, non-fibrous
- EC Number:
- 930-915-9
- Cas Number:
- 1318-02-1
- Molecular formula:
- M2/nO • Al2O3 • ySiO2 • wH2O (n is the valency of the cation M, predominantly Na, y can range from 0.64 to 8.8, and w is the number of water molecules (general formula) Na: 1.34 - 24.02%, Al: 2.20 - 39.51%, Si: 15.52 - 68.64% (general composition); additionally, depending on the water quality: Ca, Mg and K might be present below 6%
- IUPAC Name:
- Zeolite, cuboidal, crystalline, synthetic, non-fibrous
- Test material form:
- solid: particulate/powder
- Remarks:
- no surface treatment
Constituent 1
- Specific details on test material used for the study:
- name: Zeostop X (X Zeolite)
batch number: MR 453 136
description: white powder
date of receipt: 3 September 1999
storage conditions: at room temperature and protected from light
purity: 100%
expiry date: May 2000
Test animals
- Species:
- mouse
- Strain:
- Swiss
- Details on species / strain selection:
- Number: three male and three female mice for the preliminary toxicity test; 56 mice: 28 males andd 28 females for the cytogenetic study (first test); 35 female mice for the cytogenetic study (second test)
Strain: Swiss Ico: OF1 (IOPS Caw) - Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Breeder: Iffa Crédo, L'Arbresle, France
Age: on the day of treatment, the animals were at least 5 weeks old
temperature: 21 ±2°C,
relative humidity: 30 to 70%
light/dark cycle: 12 h/12 h (07:00 - 19:00)
ventilation: about 12 cycles/hour of filtered non-recycled fresh air
All animals had free access to A04C pelleted maintenance diet and tap water.
Administration / exposure
- Route of administration:
- oral: unspecified
- Vehicle:
- 0.5% aqueous methylcellulose solution: methylcellulose, batch No. 118H0286
- Duration of treatment / exposure:
- four times at a 24-hour interval
- Frequency of treatment:
- four times at a 24-hour interval
- Post exposure period:
- 24 hours after last treatment
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1 250 mg/kg bw/day (nominal)
- Dose / conc.:
- 2 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 5 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5 (first test) and 5 (females only, second test)
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide (CPA, batch No 114552) dissolved in distilled water at a concentration of 5 mg/ml
Examinations
- Tissues and cell types examined:
- For each animal, the number of the micronucleated polychromatic erythrocytes (MPE) was counted in 2000 polychromatic erythrocytes; the polychromatic (PE) and normochromatic (NE) erythrocyte ratio was established by scoring a total of 1000 erythrocytes(PE + NE).
- Details of tissue and slide preparation:
- The femurs of the animals were removed and the bone marrow was eluted out using fetal calf serum. After centrifugation, the supernatant was removed and the cells in the sediment were suspended by shaking. A drop of this cell suspension was placed and spread on a slide. The slides were air-dried and stained with Giemsa. All the slides were coded for scoring.
- Evaluation criteria:
- For a result to be considered positive, a statistically significant increase in the frequency of MPEhad to be demonstrated when compared to the concurrent vehicle control group. Reference to historical data, or other considerations of biological relevance were also taken into account in the evaluation of data obtained.
- Statistics:
- When there was no significant within-group heterogeneity, using the heterogeneity chi-square test value, the frequencies of MPE in each treated group were compared with those in the concurrent vehicle control groups by using a 2 x 2 contingency table to determine the value).
When there was significant within group heterogeneity, then that group was compared with the control group using a non-parametric analysis, the Mann-Whitney test.
The student *'!" test was usedfor the PE/NE ratio comparison.
Probability values of p <= 0.05 were considered as significant.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- Although toxic effects were observed, these were also documented for the control group (cf. below).
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
Any other information on results incl. tables
PRELIMINARY TOXICITY TEST
In order to select the top dose-level for the cytogenetic study, 5000 mg/kg/day were administered four times, to three males and three females. The interval between each administration was 24 hours. No clinical sign and no mortality were noted in both males and females.
CYTOGENETIC EXPERIMENT
For males, no mortality was noted. The clinical signs were as follows:
- At 1250 mg/kg/day, piloerection in all animals from 24 hours following the second or third treatment and until sacrifice of the animals.
- At 2500 and 5000 mg/kg/day, piloerection in 4/5 animals from 24 hours following the second treatment and until sacrifice.
For females, mortality and clinical signs were as follows:
- At 1250 mg/kg/day, 2/5 animals were found dead 24 hours after the second treatment. No clinical signs were recorded prior to death. Piloerection was noted in 2/3 surviving animals from 2 or 24 hours following the third treatment and until sacrifice.
- At 2500 mg/kg/day, 1/5 animals died 2 hours after the third treatment. Piloerection, dyspnea and hypoactivity were noted from 24 hours following the second treatment up to death. Piloerection was also recorded in 1/5 animals from 24 hours following the second treatment up to sacrifice.
- At 5000 mg/kg/day, 2/5 animals were found dead 24 hours after the first treatment. No clinical signs were observed prior to death. Piloerection was also noted in 1/3 surviving animals, from 24 hours following the second treatment up to sacrifice.
- In the control group, 1/5 animals was found dead 24 hours after the second treatment. For this female, the cause of death could not be established. However, since mortality in the vehicle group is unusual, regurgitation followed by accidental aspiration of the vehicle in the lungs could not be excluded.
Due to the low number of available animals in the vehicle control group of females (1/5 females dead and 1/5 females showed a very low PE/NE ratio (0.2), this experiment was rejected and was repeated for females only, at the same dose-levels.
In this second test, no clinical signs and no mortality were noted except at 2500 mg/kg/day, at which 1/5 females showing piloerection 24 hours after the first treatment died within the 2 hours following the second treatment.
For both males and females, the mean values of MPE in the groups treated with the test substance, were equivalent to those of the vehicle control group, and no significant difference was noted. In males given 5000 mg/kg/day, the PE/NE ratio was significantly lower (p < 0.05) compared to that of the vehicle group, providing evidence of exposure of bone marrow to the test substance. The mean values of MPE as well as the PE/NE ratio for the vehicle and positive controls were consistent with the historical data.
Cyclophosphamide induced a highly significant increase (p < 0.001) in the frequency of MPE, indicating the sensitivity of the test system under the experimental conditions. The study was therefore considered valid.
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions, the test substance ZEOSTOP X did not induce damage to the chromosomes or the mitotic apparatus of mice bone marrow cells after four oral administrations, with a 24-hour interval, at the dose levels of 1250, 2500 and 5000 mg/kg/day.
- Executive summary:
The objective of this study was to evaluate the potential of the test substance to induce damage to the chromosomes or the mitotic apparatus in bone marrow cells of mice.
Therefore, a preliminary toxicity test was performed to define the dose-levels to be used for the cytogenetic study. In the main study, three groups of five male and five female Swiss Ico: OF1 (IOPS Caw) mice received four oral treatments of Zeostop X at dose-levels of 1250, 2500 and 5000 mg/kg/day, at a 24-hour interval. Due the low number of available animals in the female vehicle control group, the experiment was repeated for females only, at the same dose-levels.
Zeostop X did not induce damage to the chromosomes or the mitotic apparatus of mice bone marrow cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.